Editor’s Choice: Can Machine Learning Help Rare Patients Get Diagnosed and Treated Faster?

Happy Friday! October is Dysautonomia Awareness Month. Dysautonomia is a collection of conditions that affect the autonomic nervous system. This can lead to a loss of control of the body's…

Continue Reading Editor’s Choice: Can Machine Learning Help Rare Patients Get Diagnosed and Treated Faster?
New NIH Study Explores PEM Symptoms in ME/CFS
Yumu123 / Pixabay

New NIH Study Explores PEM Symptoms in ME/CFS

  For patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), post-exertional malaise (PEM) can be extremely debilitating and disruptive. PEM occurs when symptoms worsen or become more severe within 12-48 hours…

Continue Reading New NIH Study Explores PEM Symptoms in ME/CFS
Experimental Renal Cell Carcinoma Combination Treatment Shows Promise in Early Trial
source: pixabay.com

Experimental Renal Cell Carcinoma Combination Treatment Shows Promise in Early Trial

According to a story from Targeted Oncology, an experimental combination therapy tested on patients with advanced clear cell renal cell carcinoma (ccRCC) appeared to show potential for efficacy in a…

Continue Reading Experimental Renal Cell Carcinoma Combination Treatment Shows Promise in Early Trial

Owlstone Medical Announces Successful Study Using Breath Biopsy to Measure Liver Function

Owlstone Medical recently announced the success of its patient study demonstrating its Breath Biopsy®, using limonene as a biomarker in measuring liver function. The study demonstrated how exhaled limonene, a…

Continue Reading Owlstone Medical Announces Successful Study Using Breath Biopsy to Measure Liver Function
American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign
source: pixabay.com

American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign

According to a press release from the American Kidney Fund (AKF), the organization, which is dedicated to fighting kidney disease, has partnered with the biotech company Sanofi Genzyme in a…

Continue Reading American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign
Dr. Lin Weighs in on the Controversy of Whether Asymptomatic People Can Spread COVID-19
source: pixabay.com

Dr. Lin Weighs in on the Controversy of Whether Asymptomatic People Can Spread COVID-19

The number of people who have been infected with the coronavirus has now surpassed the SARs virus. Dr. Peter Lin, Director at the Heart Research Center in Canada, questions the…

Continue Reading Dr. Lin Weighs in on the Controversy of Whether Asymptomatic People Can Spread COVID-19
Close Menu